In vitro studies using human lung fibroblasts have confirmed that circ_0001861 modulates the miR-296-5p/BBC3 (BCL2 binding component 3) axis to mitigate pulmonary fibrosis (Wu T. et al., 2023). Here, BBC3 is linked to pulmonary fibrosis.